Tarro G, Sabin A B
Proc Natl Acad Sci U S A. 1970 Mar;65(3):753-60. doi: 10.1073/pnas.65.3.753.
The search for a specific, serologically identifiable nonvirion antigen (i.e., not a structural component of the virus) in cells infected with herpes simplex virus (HSV) was undertaken as an approach to the problem of the possible role of this virus in certain types of human cancer.Synthesis of structural components of HSV could not be prevented by a variety of inhibitors of DNA synthesis or by incubation at certain high or low temperatures, and it was, therefore, necessary to devise methods for the detection of nonvirion antigen in the presence of virion antigens. This was achieved by means of specially prepared and absorbed antisera only after the unusual lability and sedimentability of the nonvirion component became apparent. The special sera were derived from guinea pigs hyperimmunized with uncentrifuged extracts of guinea pig kidney culture cells freshly prepared three hours after infection with 20 to 30 plaque-forming units (PFU) of HSV per cell. It was possible to remove the neutralizing (N) antibodies for live virus and the complement-fixing (CF) antibodies for the sedimentable and soluble virion antigens, without loss of CF antibodies for nonvirion antigen, by absorption of these sera with uncentrifuged, HSV infected cell extracts that had been stored at +4 degrees or -66 degrees C, or both, for a sufficiently long time to permit the disappearance of the labile, nonvirion components. Human, rabbit, and guinea pig sera obtained after infection or after "ordinary" hyperimmunization had no CF antibodies for the labile, nonvirion antigen after comparable absorption. The nonvirion antigen detected in this manner is specific not only for HSV but also for the type (or strain?) of HSV, since infection of guinea pig kidney culture cells with vaccinia virus or type 2 (genital) HSV yielded no antigen detectable with the absorbed serum prepared against the type 1 HSV strain; the type 2 HSV produced large amounts of type 1 HSV virion antigen under these conditions, and the vaccinia virus large amounts of antigen reactive with ordinary rabbit antivaccinial serum. The nonvirion antigen was formed at maximum concentration early (3 hr) after high multiplicity HSV infection in guinea pig cells but late in the infectious process (12-24 hr) in rabbit or HEp 2 cells. The supernatant fluid had only 50 per cent of the activity after centrifugation at 1500 g for ten minutes and none after a further centrifugation at 33,360 g for one hour. Storage at +4 degrees C for eight to nine days led to complete loss of activity of the nonvirion antigen but no loss of activity of the various sedimentable and soluble virion antigens. At -66 degrees C or lower temperatures 50 per cent of the activity was lost in seven days and further loss occurred at different rates in extracts of guinea pig, rabbit and HEp 2 cells.
人们对感染单纯疱疹病毒(HSV)的细胞中一种特定的、血清学上可识别的非病毒体抗原(即不是病毒的结构成分)进行了研究,以此作为探讨该病毒在某些类型人类癌症中可能作用的一种方法。多种DNA合成抑制剂或在特定的高温或低温下孵育都无法阻止HSV结构成分的合成,因此,有必要设计出在病毒体抗原存在的情况下检测非病毒体抗原的方法。只有在非病毒体成分表现出异常的不稳定性和沉降性之后,才通过特制的、经过吸收处理的抗血清实现了这一点。这些特殊的血清来自用每细胞感染20至30个空斑形成单位(PFU)的HSV后三小时新鲜制备的豚鼠肾培养细胞的未离心提取物对豚鼠进行超免疫而获得。通过用在+4℃或-66℃或两者保存足够长时间以使不稳定的非病毒体成分消失的未离心的、HSV感染细胞提取物吸收这些血清,可以去除针对活病毒的中和(N)抗体以及针对可沉降和可溶性病毒体抗原的补体结合(CF)抗体,而不会损失针对非病毒体抗原的CF抗体。感染后或“普通”超免疫后获得的人、兔和豚鼠血清在经过类似吸收后,对不稳定的非病毒体抗原没有CF抗体。以这种方式检测到的非病毒体抗原不仅对HSV具有特异性,而且对HSV的类型(或毒株?)也具有特异性,因为用痘苗病毒或2型(生殖器型)HSV感染豚鼠肾培养细胞后,用针对1型HSV毒株制备的吸收血清检测不到任何抗原;在这些条件下,2型HSV产生大量1型HSV病毒体抗原,而痘苗病毒产生大量与普通兔抗痘苗血清反应的抗原。非病毒体抗原在豚鼠细胞中高复数HSV感染后早期(3小时)形成最大浓度,但在兔或HEp 2细胞的感染过程后期(12 - 24小时)形成。将上清液在1500 g下离心十分钟后,其活性仅为原来的50%,再在33360 g下离心一小时后则无活性。在+4℃下储存八至九天会导致非病毒体抗原的活性完全丧失,但各种可沉降和可溶性病毒体抗原的活性不会丧失。在-66℃或更低温度下,七天内50%的活性丧失,并且在豚鼠、兔和HEp 2细胞的提取物中以不同速率进一步丧失活性。